title: [Prognostic significance of CA19-9 levels in patients with pancreatic cancer].
authors.affiliation: Department of Surgery, Tokyo Women's Medical University Medical Center East.
authors.forename: Shunichi
authors.initials: S
authors.lastname: Shiozawa
authors.forename: Akira
authors.initials: A
authors.lastname: Tsuchiya
authors.forename: Dal Ho
authors.initials: DH
authors.lastname: Kim
authors.forename: Kenji
authors.initials: K
authors.lastname: Ogawa
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D003841:Deoxycytidine; D000093542:Gemcitabine